Boston.com
Local Search Site Search
Home Delivery
  • Home
  • Today's Globe
  • News
  • Your Town
  • Business
  • Sports
  • Lifestyle
  • A&E
  • Things to do
  • Travel
  • Cars
  • Jobs
  • Real Estate
  • Technology
  • Healthcare
  • Markets
  • Personal finance
  • Columnists

Key moments in Genzyme's history

1991 - Key drug approved by the FDA Ceredase, a treatment for Gaucher's disease, gains FDA approval after seven years of work on the drug by Genzyme. First patients pay over $300,000 for the first year of treatment, making it one of the most expensive medications in the world. Pictured: A photo showing a reunion of nine of the original 12 participants in the Ceredase clinical trial hangs in Termeer's office.
Reuters Photo
  • Prev
  • 1
  • ...
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • ...
  • 17
  • Next
Related
  • Genzyme agrees to $20.1b sale to drug giant

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

  • E-mail
  • Facebook
  • Twitter
  • Digg
  • ShareThis
  • Prev
  • 6 of 17
  • Next
Compiled by Jesse Nunes, Boston.com Staff

1991 - Key drug approved by the FDA

Ceredase, a treatment for Gaucher's disease, gains FDA approval after seven years of work on the drug by Genzyme. First patients pay over $300,000 for the first year of treatment, making it one of the most expensive medications in the world.

Pictured: A photo showing a reunion of nine of the original 12 participants in the Ceredase clinical trial hangs in Termeer's office.

  • Home
  • |
  • Today's Globe
  • |
  • News
  • |
  • Business
  • |
  • Sports
  • |
  • Lifestyle
  • |
  • A&E
  • |
  • Things to Do
  • |
  • Travel
  • |
  • Cars
  • |
  • Jobs
  • |
  • Real Estate
  • |
  • Local Search
  • Contact Boston.com
  • |
  • Help
  • |
  • Advertise
  • |
  • Work here
  • |
  • Privacy Policy
  • |
  • Your Ad Choices
  • |
  • Terms of Service
  • |
  • Newsletters
  • |
  • Mobile
  • |
  • RSS feeds
  • |
  • Sitemap
  • Contact The Boston Globe
  • |
  • Subscribe
  • |
  • Manage your subscription
  • |
  • Advertise
  • |
  • Boston Globe Insiders
  • |
  • The Boston Globe Gallery
  • |
  • © Boston Globe Media Partners, LLC